Lv31
330 积分 2021-08-30 加入
Genetic and transcriptional evolution alters cancer cell line drug response
9天前
已完结
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
1个月前
已完结
Discovery of the First Potent PI3K/mTOR Dual-Targeting PROTAC Degrader for Efficient Modulation of the PI3K/AKT/mTOR Pathway
1个月前
已完结
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression
1个月前
已关闭
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression
1个月前
已关闭
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
1个月前
已完结
Regulation of the PI3K/AKT/mTOR cascade in Hepatocellular Carcinoma Using Flavonoid Molecules
1个月前
已完结
FH-2001 is a novel FGFR/VEGFR dual inhibitor with immune-modulating activity
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
